Organon & Co. SEC filings OGN
Organon & Co. has 461 filings in SEC EDGAR's recent list, going back to Nov 2, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2026 | Oct 30, 2026 |
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 31, 2026 | Jul 31, 2026 |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 23, 2026 | Jul 23, 2026 |
| DEFA14A | Additional proxy material | Jul 17, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 17, 2026 | Jul 17, 2026 |
| DEFM14A | Filing | Jun 17, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2026 | Jun 9, 2026 |
| DEFA14A | Additional proxy material | Jun 11, 2026 | — |
| PREM14A | Filing | Jun 1, 2026 | May 29, 2026 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2026 | — |
| 10-Q | Quarterly report | May 4, 2026 | Mar 31, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| 8-K |
Current report
Results of operations
|
Apr 30, 2026 | Apr 30, 2026 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Apr 27, 2026 | Apr 26, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 9, 2026 |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Feb 20, 2026 | Feb 20, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 12, 2026 | Feb 12, 2026 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q/A | Amended quarterly report | Nov 10, 2025 | Jun 30, 2025 |
| 10-Q/A | Amended quarterly report | Nov 10, 2025 | Mar 31, 2025 |
| 10-K/A | Amended annual report | Nov 10, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 7, 2025 | Nov 3, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 30, 2025 | Oct 26, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 27, 2025 | Oct 26, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| S-8 | Employee stock plan registration | Jun 13, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2025 | — |
| 8-K |
Current report
Other events
|
May 27, 2025 | May 27, 2025 |
| 10-Q | Quarterly report | May 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
May 1, 2025 | May 1, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 15, 2025 | Apr 15, 2025 |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 13, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 21, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Other events
|
Dec 23, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 6, 2024 | Dec 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 5, 2024 | Nov 5, 2024 |
| 10-Q | Quarterly report | Nov 1, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 23, 2024 | Sep 17, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| UPLOAD | Letter from the SEC | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 6, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 4, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2024 | — |
| UPLOAD | Letter from the SEC | May 23, 2024 | — |
| 8-K |
Current report
Material agreement, New debt
|
May 17, 2024 | May 17, 2024 |
| CORRESP | Letter to the SEC | May 14, 2024 | — |
| 10-Q | Quarterly report | May 3, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 2, 2024 | May 2, 2024 |
| UPLOAD | Letter from the SEC | Apr 30, 2024 | — |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 4, 2024 |
| 10-K | Annual report | Feb 26, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 15, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 5, 2023 | Dec 1, 2023 |
| 10-Q | Quarterly report | Nov 3, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 6, 2023 |
| 10-Q | Quarterly report | May 5, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 4, 2023 | May 4, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | — |
| 10-K | Annual report | Feb 27, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 16, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 9, 2022 | Dec 6, 2022 |
| 10-Q | Quarterly report | Nov 4, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2022 | Nov 3, 2022 |
| 10-Q | Quarterly report | Aug 5, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 12, 2022 | Jul 7, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 6, 2022 | May 5, 2022 |
| 10-Q | Quarterly report | May 6, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2022 | May 5, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 7, 2022 |
| 10-K | Annual report | Mar 21, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 17, 2022 | Feb 17, 2022 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2021 | Nov 11, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2021 | Jun 29, 2021 |
| 10-Q | Quarterly report | Jun 21, 2021 | Mar 31, 2021 |
| S-8 | Employee stock plan registration | Jun 3, 2021 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 3, 2021 | Jun 2, 2021 |
| SEC STAFF LETTER | Filing | May 7, 2021 | — |
| SEC STAFF ACTION | Filing | May 7, 2021 | — |
| CORRESP | Letter to the SEC | May 5, 2021 | — |
| CERT | Nyse certification | May 5, 2021 | — |
| 10-12B/A | Filing | Apr 29, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2021 | — |
| 10-12B/A | Filing | Apr 14, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 24, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2021 | — |
| 10-12B | Filing | Mar 17, 2021 | — |
| DRSLTR | Filing | Dec 21, 2020 | — |
| DRS/A | Filing | Dec 21, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2020 | — |
| DRS | Filing | Nov 2, 2020 | — |
Showing 123 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OGN (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Jersey City, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1821825
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.